Neocodex Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

Neocodex General Information

Description

Provider of genomic research, analysis and biomaterials. The company is engaged in genomic discovery, diagnostics and drug development. It owns patents on genetic markers related to cardiovascular risf, osteoporosis and reproductive abnormalities, and is the creator of a major bio-bank representing a wide range of pharmaceutically relevant diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Avda. Charles Darwin
  • s/n. Isla de la Cartuja. Pabellón
  • 41092 Seville
  • Spain
+34 955
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Discovery Tools (Healthcare)
Vertical(s)
Life Sciences
Corporate Office
  • Avda. Charles Darwin
  • s/n. Isla de la Cartuja. Pabellón
  • 41092 Seville
  • Spain
+34 955

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neocodex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-May-2011 Completed Generating Revenue
2. Early Stage VC 30-Mar-2006 Completed Startup
1. Early Stage VC 01-Jul-2003 Completed Startup
To view Neocodex’s complete valuation and funding history, request access »

Neocodex Patents

  • 18

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Neocodex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2090588-A1 In vitro method for prognosis and/or diagnosis of hypersensitivity to ooestrogens or to substances with ooestrogenic activity Inactive 23-Oct-2006
EP-2090588-A4 In vitro method for prognosis and/or diagnosis of hypersensitivity to ooestrogens or to substances with ooestrogenic activity Inactive 23-Oct-2006
WO-2008049953-A1 In vitro method for prognosis and/or diagnosis of hypersensitivity to ooestrogens or to substances with ooestrogenic activity Inactive 23-Oct-2006
JP-2009523285-A Method and apparatus for determining genetic association Pending 11-Jan-2006
EP-1975255-A2 Method and apparatus for the determination of genetic associations Inactive 11-Jan-2006 G16B20/20
To view Neocodex’s complete patent history, request access »

Ready to get started?

Request a free trial

Neocodex FAQs

  • When was Neocodex founded?

    Neocodex was founded in 2002.

  • Where is Neocodex headquartered?

    Neocodex is headquartered in Seville, Spain.

  • What industry is Neocodex in?

    Neocodex’s primary industry is Biotechnology.

  • Is Neocodex a private or public company?

    Neocodex is a Private company.

  • What is Neocodex’s current revenue?

    The current revenue for Neocodex is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process